Dr. John Cush RheumNow
4 years 10 months ago
Treat to Target in SLE: Dr. Yuzaiful Yusof ( @Yuz6Yusof ) reviews abstract #0865 presented at the #ACR21 annual meeting.
https://t.co/THX4nLWCaR https://t.co/951HAdkONi
Safety comparisons of JAKi (tofacitinib) vs. TNFi from Oral Surveillance showed that, in patients with active RA on MTX and aged >50 years with one or more CV risk factors, that there was numerically more MACE events, malignancies, and VTE especially in higher dose.
A study from ACR21 convergence discussing data from the Global Rheumatology Alliance (GRA) describes the association between race/ethnicity on COVID-19 outcomes specifically in lupus patients.
Dr. John Cush RheumNow
4 years 10 months ago
ICYMI: Dr. Aurelie Nahm ( @AurelieRheumo) shares #ACR21 presentation findings on TNF inhibitors and radiographic progression in axSpA
https://t.co/nDh6sT1MzX https://t.co/5Ri13bfYOV
Dr. John Cush RheumNow
4 years 10 months ago
ICYMI: New Insights into Uveitis in Spondyloarthritis
There have been some updates on uveitis in SpA at #ACR21 shared by Dr. Antoni Chan ( @synovialjoints).
https://t.co/lyKt8p5s4o https://t.co/A9tRmD4mBJ https://t.co/TZPThjrazR
Dr. John Cush RheumNow
4 years 10 months ago
ICYMI: To Clot or Not to Clot with Drs. Janet Pope ( @Janetbirdope) and Jeffrey Sparks ( @jeffsparks )
#ACR21
https://t.co/HL6rGMqFRN https://t.co/YeWP4kKJhD https://t.co/7DyIXPPOLL
Dr. John Cush RheumNow
4 years 10 months ago
ICYMI: Monitoring Infliximab Drug Levels Improves Efficacy
Should we start considering therapeutic drug monitoring when prescribing TNFi for treatment of our rheumatologic conditions?
Dr. Robert Chao ( @doctorRBC) shares data presented at #ACR21.
https://t.co/zkxvUrsczd
Dr. John Cush RheumNow
4 years 10 months ago
ICYMI:
Watch: Lupus Updates: Dr. Michelle Petri
Dr. Michelle Petri offers perspective and insight into lupus related data presented Saturday at the #ACR21 annual meeting.
https://t.co/nluRreQPT1 https://t.co/fzm1RW6Rpy
Dr. John Cush RheumNow
4 years 10 months ago
In case you missed it…
Watch: What's Cool and Hot in Vasculitis with Dr. Janet Pope (@Janetbirdope ) #ACR21
https://t.co/JbhQWeejy7 https://t.co/qlCCk3MXKu
Dr. John Cush RheumNow
4 years 10 months ago
ICYMI:Identifying Gaps in axSpA: Lessons from European Map of Axial Spondyloarthritis (EMAS)
Dr. Sheila Reyes(@RHEUMarampa) discusses the three interesting abstracts were presented by the group of Prof. Marco Garrido-Cumbrera on the EMAS at #ACR21.
https://t.co/5kOv5BUU4P https://t.co/lKuXC0mLRt
Dr. John Cush RheumNow
4 years 10 months ago
ICYMI: Risankizumab for Active Psoriatic Arthritis with Dr. Robert Chao ( @doctorRBC )
#ACR21
https://t.co/jRLem8YWpv https://t.co/5EQB1Y38Xs
Dr. John Cush RheumNow
4 years 10 months ago
ICYMI: COVID in Rheumatologic Disease Patients: Drs. Sparks, Liew, Yazdany and Dao provide an update on data specific to COVID in rheumatologic disease patients.
@jeffsparks @drdavidliew @KDAO2011
#ACR21
https://t.co/jDGCpyTaPa https://t.co/58aehXyNzY
Dr. John Cush RheumNow
4 years 10 months ago
ICYMI: Towards better assessment and management of multimorbidity by Dr. Mrinalini Dey ( @DrMiniDey ) #ACR21
https://t.co/5G7PkWYrOH https://t.co/olsfrCyJw5
Dr. John Cush RheumNow
4 years 10 months ago
RheumNow Podcast - #ACR21 Rehash (the good stuff…)
The ACR 2021 meeting has concluded. Dr. Jack Cush recounts a few more great abstracts from this past week’s virtual meeting.
https://t.co/6tuiajP4O7 https://t.co/cZeeVmrHqR
